BROOKLYN COMMUNITY CLINICAL ONCOLOGY PROGRAM

布鲁克林社区临床肿瘤学计划

• 批准号: 3559016
• 负责人: SAMEER S RAFLA
• 金额: $ 11.75万
• 依托单位: NEW YORK METHODIST HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1991
• 资助国家: 美国
• 起止时间: 1991-09-30 至 1994-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3559016
• 关键词: 13 cis retinoate; Hodgkin's disease; acute leukemia; adenocarcinoma; androgen inhibitor; antineoplastics; autologous transplantation; bladder neoplasm; bleomycin; bone marrow transplantation; breast neoplasm /cancer diagnosis; breast neoplasms; breast surgery; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; cancer risk; carcinogenesis inhibitor; central nervous system neoplasms; chemoprevention; chlorambucil; cis platinum compound; clinical trials; colorectal neoplasms; combination chemotherapy; community health services; cooperative study; cyclophosphamide; cytosine arabinoside; dacarbazine; deoxycoformycin; doxorubicin; esophagus neoplasm; etoposide; fluorouracil; head /neck neoplasm; health science research analysis /evaluation; homologous transplantation; human subject; human therapy evaluation; leucovorin; levamisole; lomustine; lymphoma; mechlorethamine; methotrexate; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer nutrition therapy; neoplasm /cancer radionuclide therapy; neoplasm /cancer surgery; neoplasm /cancer therapy; nutrition related tag; prednisone; procarbazine; prostate neoplasms; radiosensitizer; sarcoma; small cell lung cancer; smoking cessation; tamoxifen; therapy compliance; vincristine

This application from the Cancer Institute of Brooklyn (CIB) is submitted in response to RFA 90-CA-13. The applicant organization, the CIB, is a free-standing entity supported by two of the consortium institutions, and affiliated with the other two. The CIB will serve as the "umbrella" and central focus of this research effort. All four hospitals are located in the southern half of the borough of Brooklyn with a catchment area of more than 1 million people. Fifty board-certified physicians have committeed their support to this project, which anticipates contributing 120 patients to clinical treatment trials and 92 to cancer control studies. This will be accomplished through agreements with three research bases: NSABP, ECOG, and RTOG. The specific aims developed for the Brooklyn CCOP are: 1) Coordination and expansion of existing research resources; 2) development and support of the investigators' research; 3) provision of comprehensive data management support; 4) collaboration with the research bases to optimize accrual; 5) expansion of the data management system; 6) development of a patient identification process; 7) implementation of a quality control program; 8) execution of a protocol selection process; 9) enforcement of investigator standards; 10) expansion of existing cancer control protocol activities; 11) increasing the involvement and awareness of primary care physicians; 12) expansion of this research effort to include other physicians and/or institutions in the catchment area; and 15) dissemination of research information to the Brooklyn medical community. Experienced physician leadership and support staff in addition to well- equipped facilities will enhance the development and implementation of this community research effort.

布鲁克林癌症研究所（CIB）的应用是 根据RFA 90-CA-13提交。 申请人组织， CIB是一个由两个财团支持的独立实体 机构，并隶属于其他两个机构。 CIB将作为 这项研究工作的“伞”和重点。 全部四个 医院位于布鲁克林自治市镇的南部 一个集水区超过100万人。 五十 经过董事会认证的医师对此表示支持 项目，预计为临床贡献120名患者 治疗试验和92例癌症控制研究。 这将是 通过与三个研究基础的协议完成：NSABP，ECOG， 和rtog。 布鲁克林CCOP开发的具体目标是：1）协调 和现有研究资源的扩展； 2）发展和支持 研究人员的研究； 3）提供综合数据 管理支持； 4）与研究基础合作以优化 应计； 5）扩展数据管理系统； 6）发展 患者识别过程； 7）实施质量控制 程序; 8）执行协议选择过程； 9）执行 研究者标准； 10）扩大现有癌症控制 协议活动； 11）提高参与和意识 初级保健医生； 12）将这项研究工作扩展到 在集水区中包括其他医生和/或机构；和 15）将研究信息传播给布鲁克林医学 社区。 经验丰富的医师领导和支持员工除了 设备配备的设施将增强和实施 这项社区研究工作。